Importantly, inhibition of both RALA and RALB with the nonselective RAL inhibitor BQU57 significantly reduced tumor growth and metastasis in the TNBC cell line MDA-MB-231 and patient-derived xenograft models [22]. The gene discussed is RALB; the disease is neoplasm.